about
Refractory status epilepticus in children with and without prior epilepsy or status epilepticus.Time from convulsive status epilepticus onset to anticonvulsant administration in children.Pharmacologic management of convulsive status epilepticus in childhood.Development of pharmacoresistance to benzodiazepines but not cannabinoids in the hippocampal neuronal culture model of status epilepticus.Comparison of drug delivery with autoinjector versus manual prefilled syringe and between three different autoinjector devices administered in pig thighEmergency management of febrile status epilepticus: results of the FEBSTAT studyClinical practice: the treatment of acute convulsive seizures in children.Mechanisms of levetiracetam in the control of status epilepticus and epilepsy.Therapeutic choices in convulsive status epilepticus.First aid for seizures: the importance of education and appropriate response.Pharmacokinetics of diazepam administered intramuscularly by autoinjector versus rectal gel in healthy subjects: a phase I, randomized, open-label, single-dose, crossover, single-centre study.Stiripentol in refractory status epilepticus.Analysis of the delay components in the treatment of status epilepticus.Factors related to delays in pre-hospital management of status epilepticus.Timing is everything: Where status epilepticus treatment fails.Factors associated with treatment delays in pediatric refractory convulsive status epilepticus.Status Epilepticus in Children.
P2860
Q30275157-67CDEC6F-9F71-4ADC-BE97-68506B30BF28Q30299985-4E8556E1-4DB4-4622-81E6-2AECABD64FCAQ34465801-EC20B966-3B64-4843-8F8E-7EE9ADE2AADBQ36168793-C900ADF2-18D2-4FBA-B489-A8D104DF8DB4Q37158507-BFBC643A-E1AB-4B07-857F-EBC3CBF0A448Q37646962-B991CC13-E918-474E-B211-943CA40C15B5Q37837618-34CFB1E7-31C3-4469-82E6-9BD952499F0DQ38189350-5D862C19-9A60-495B-B785-8D38D4383CAAQ38334273-4F7D9D95-CDF6-4121-8C85-84000873CA8BQ44931456-CDD6644A-9837-49E3-8EE1-EE5BF689AA06Q44967343-D90650BA-47FC-41AC-994D-A2BF4EFDE936Q45758314-A374A97A-C38A-444A-87A4-F447D3FDDB7FQ46332785-11D1642A-4E09-43A6-AE07-0574BA68F350Q46423797-D154C375-8077-49EF-90A7-54C16BDCA0A4Q50543732-5F78D172-8482-436F-B618-C03687AB8A17Q52593315-B0F7D42A-8884-48C7-90C0-F65217C01E14Q54473085-4F733DFA-154A-4D88-8275-A8AD5F54D3DC
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Time to treatment in prolonged seizure episodes.
@en
Time to treatment in prolonged seizure episodes.
@nl
type
label
Time to treatment in prolonged seizure episodes.
@en
Time to treatment in prolonged seizure episodes.
@nl
prefLabel
Time to treatment in prolonged seizure episodes.
@en
Time to treatment in prolonged seizure episodes.
@nl
P2093
P1433
P1476
Time to treatment in prolonged seizure episodes.
@en
P2093
Anthony Marmarou
John M Pellock
Robert DeLorenzo
P304
P356
10.1016/J.YEBEH.2003.12.012
P577
2004-04-01T00:00:00Z